Infliximab backed for IBD
23 March 2009
| by Tony James
The efficacy of long-term infliximab treatment for inflammatory bowel disease has been supported by follow-up of more than 600 patients with Crohn’s disease treated for a median of 55 months....
Want to read complete article? Please Sign in or Register.